BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7943015)

  • 1. Butyrate and acetyl-carnitine inhibit the cytogenetic expression of the fragile X in vitro.
    Pomponi MG; Neri G
    Am J Med Genet; 1994 Jul; 51(4):447-50. PubMed ID: 7943015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of the common fragile site at Xq27.2 under conditions of thymidylate stress: implications for cytogenetic diagnosis of the fragile-X syndrome.
    Ramos FJ; Emanuel BS; Spinner NB
    Am J Med Genet; 1992 Apr; 42(6):835-8. PubMed ID: 1532475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of expansion of CGG repeats and X-inactivation with expression of fra(X)(q27.3) in heterozygotes.
    Mingroni-Netto RC; Fernandes JG; Vianna-Morgante AM
    Am J Med Genet; 1994 Jul; 51(4):443-6. PubMed ID: 7943014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragile X syndrome.
    Laxova R
    Adv Pediatr; 1994; 41():305-42. PubMed ID: 7992687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragile X induction systems in CVS cultures: effect on cytogenetic, PCR, and genomic Southern Blot DNA analyses of the FMR-1 gene.
    Jenkins EC; Morys I; Henderson J; Genovese M; Carter M; Li SY; Houck GE; Ding X; Stark-Houck SL; Dobkin CS
    Am J Med Genet; 1994 Jul; 51(4):436-42. PubMed ID: 7943013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytogenetic studies in fragile X syndrome].
    Nowicki GA
    Pol Tyg Lek; 1992 Mar 2-9; 47(9-10):211-4. PubMed ID: 1437821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservation of CGG region in FMR1 gene in mammals.
    Deelen W; Bakker C; Halley DJ; Oostra BA
    Am J Med Genet; 1994 Jul; 51(4):513-6. PubMed ID: 7943032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Variations in the presence of a fragile site on X--fra(X)--according to cases and methods used].
    Crippa L; Delozier-Blanchet CD; Engel E
    J Genet Hum; 1984 Jul; 32(3):193-7. PubMed ID: 6481341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fragile X syndrome I: familial variation in the proportion of lymphocytes with the fragile site in males.
    Soudek D; Partington MW; Lawson JS
    Am J Med Genet; 1984 Jan; 17(1):241-52. PubMed ID: 6711598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic guidelines for fragile X studies tested in routine practice.
    Dewald GW; Buckley DD; Spurbeck JL; Jalal SM
    Am J Med Genet; 1992 Dec; 44(6):816-21. PubMed ID: 1481854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of mental status in carriers of the fragile X mutation using CGG repeat length.
    Smits A; Smeets D; Hamel B; Dreesen J; de Haan A; van Oost B
    Am J Med Genet; 1994 Jul; 51(4):497-500. PubMed ID: 7943027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of fragile X syndrome in a sample from Spanish Basque country.
    Arrieta I; Criado B; Martinez B; Telez M; NuƱez T; PeƱagarikano O; Ortega B; Lostao CM
    Ann Genet; 1999; 42(4):197-201. PubMed ID: 10674158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm.
    Reyniers E; Vits L; De Boulle K; Van Roy B; Van Velzen D; de Graaff E; Verkerk AJ; Jorens HZ; Darby JK; Oostra B
    Nat Genet; 1993 Jun; 4(2):143-6. PubMed ID: 8348152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excess thymidine induces folate sensitive fragile sites.
    Sutherland GR; Baker E; Fratini A
    Am J Med Genet; 1985 Oct; 22(2):433-43. PubMed ID: 4050872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental therapy: reactivation of the FMR1 gene involved in fragile X syndrome].
    Chiurazzi P; Neri G
    Rev Neurol; 2001 Oct; 33 Suppl 1():S62-5. PubMed ID: 12447822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragile X syndrome and deletions in FMR1: new case and review of the literature.
    Hammond LS; Macias MM; Tarleton JC; Shashidhar Pai G
    Am J Med Genet; 1997 Nov; 72(4):430-4. PubMed ID: 9375726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A point mutation in the FMR-1 gene associated with fragile X mental retardation.
    De Boulle K; Verkerk AJ; Reyniers E; Vits L; Hendrickx J; Van Roy B; Van den Bos F; de Graaff E; Oostra BA; Willems PJ
    Nat Genet; 1993 Jan; 3(1):31-5. PubMed ID: 8490650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Variability in the expression of the fragile site of the (fra)X chromosome in 2 consecutive cell cycles].
    Zakharov AF; Bedel'baeva KhA; Baranovskaia LI
    Biull Eksp Biol Med; 1986 Dec; 102(12):738-41. PubMed ID: 3801629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fragile X phenotype in a mosaic male with a deletion showing expression of the FMR1 protein in 28% of the cells.
    de Graaff E; de Vries BB; Willemsen R; van Hemel JO; Mohkamsing S; Oostra BA; van den Ouweland AM
    Am J Med Genet; 1996 Aug; 64(2):302-8. PubMed ID: 8844070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unstable triplets and their mutational mechanism: size reduction of the CGG repeat vs. germline mosaicism in the fragile X syndrome.
    Chiurazzi P; Kozak L; Neri G
    Am J Med Genet; 1994 Jul; 51(4):517-21. PubMed ID: 7943033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.